Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.

被引：0
|
作者：
Harker, LA
Marzec, UM
Novembre, F
Sundell, IB
Waller, EK
Karpatkin, S
McClure, HM
Kelly, AB
Stead, RB
机构：
[1] EMORY UNIV,ATLANTA,GA 30322
[2] NYU,MED CTR,NEW YORK,NY 10016
[3] AMGEN INC,THOUSAND OAKS,CA 91320
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：754 / 754
页数：1
相关论文
共 50 条
  • [1] Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor
    Harker, LA
    Marzec, UM
    Novembre, F
    Sundell, IB
    Waller, EK
    Karpatkin, S
    McClure, HM
    Kelly, AB
    Stead, RB
    BLOOD, 1998, 91 (12) : 4427 - 4433
  • [2] Recombinant human megakaryocyte growth and development factor attenuates postbypass thrombocytopenia
    Nakamura, M
    Toombs, CF
    Duarte, IG
    Ronson, RS
    Schmarkey, IS
    Katzmark, SL
    Robinson, J
    Dillehay, DL
    Vinten-Johansen, J
    Guyton, RA
    ANNALS OF THORACIC SURGERY, 1998, 66 (04): : 1216 - 1223
  • [3] Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice
    Kabaya, K
    Shibuya, K
    Torii, Y
    Nitta, Y
    Ida, M
    Akahori, H
    Kato, T
    Kusaka, M
    Miyazaki, H
    BONE MARROW TRANSPLANTATION, 1996, 18 (06) : 1035 - 1041
  • [4] Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice
    Akahori, H
    Shibuya, K
    Ozai, M
    Ida, M
    Kabaya, K
    Kato, T
    Miyazaki, H
    STEM CELLS, 1996, 14 (06) : 678 - 689
  • [5] Marked improvement of thrombocytopenia in a murine model of idiopathic thrombocytopenic purpura by pegylated recombinant human megakaryocyte growth and development factor
    Shibuya, K
    Kuwaki, T
    Tahara, E
    Yuki, C
    Akahori, H
    Kato, T
    Miyazaki, H
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (10) : 1185 - 1192
  • [6] Erratum: Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice
    K Kabaya
    K Shibuya
    Y Torii
    Y Nitta
    M Ida
    H Akahori
    T Kato
    M Kusaka
    H Miyazaki
    Bone Marrow Transplantation, 1997, 20 : 619 - 620
  • [7] Pegylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice
    Shibuya, K
    Kuwaki, T
    Akahori, H
    Kato, T
    Miyazaki, H
    LEUKEMIA RESEARCH, 2004, 28 (09) : 941 - 946
  • [8] Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
    Nomura, S
    Dan, K
    Hotta, T
    Fujimura, K
    Ikeda, Y
    BLOOD, 2002, 100 (02) : 728 - 730
  • [9] PEGylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice.
    Shibuya, K
    Akahori, H
    Tahara, E
    Kato, T
    Miyazaki, H
    BLOOD, 1997, 90 (10) : 757 - 757
  • [10] In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice
    Kabaya, K
    Akahori, H
    Shibuya, K
    Nitta, Y
    Ida, M
    Kusaka, M
    Kato, T
    Miyazaki, H
    STEM CELLS, 1996, 14 (06) : 651 - 660
12345